Giant Biogene Holding Co Ltd.'s Controlling Shareholder Plans HK$200 Million Equity Investment Increase

Reuters

06-09

Giant Biogene Holding Co Ltd.'s Controlling Shareholder Plans HK$200 Million Equity Investment Increase

Giant Biogene Holding Co., Ltd, a company incorporated in the Cayman Islands, has announced a proposed increase in shareholding by its controlling shareholder, Juzi Holding Co., Ltd. The plan involves Juzi Holding investing no less than HK$200 million to increase its stake in Giant Biogene within the next three to six months. Currently, Juzi Holding owns approximately 54.26% of the company's issued shares. This strategic move is based on Juzi Holding's confidence in the company's business development and growth potential. The Board of Giant Biogene views this action as a demonstration of the controlling shareholder's long-term commitment and strong confidence in the company's prospects. Shareholders and potential investors are advised to exercise caution when dealing with the company's shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2542389874"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542389874\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2542389874?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-09 12:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542389874","market":"us","top_or_hot":-1,"title":"Giant Biogene Holding Co Ltd.'s Controlling Shareholder Plans HK$200 Million Equity Investment Increase","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Giant Biogene Holding Co Ltd.'s Controlling Shareholder Plans HK$200 Million Equity Investment Increase\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Giant Biogene Holding Co., Ltd, a company incorporated in the Cayman Islands, has announced a proposed increase in shareholding by its controlling shareholder, Juzi Holding Co., Ltd. The plan involves Juzi Holding investing no less than HK$200 million to increase its stake in Giant Biogene within the next three to six months. Currently, Juzi Holding owns approximately 54.26% of the company's issued shares. This strategic move is based on Juzi Holding's confidence in the company's business development and growth potential. The Board of Giant Biogene views this action as a demonstration of the controlling shareholder's long-term commitment and strong confidence in the company's prospects. Shareholders and potential investors are advised to exercise caution when dealing with the company's shares.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Giant Biogene Holding Co Ltd.'s Controlling Shareholder Plans HK$200 Million Equity Investment Increase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGiant Biogene Holding Co Ltd.'s Controlling Shareholder Plans HK$200 Million Equity Investment Increase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-09 12:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Giant Biogene Holding Co Ltd.'s Controlling Shareholder Plans HK$200 Million Equity Investment Increase\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Giant Biogene Holding Co., Ltd, a company incorporated in the Cayman Islands, has announced a proposed increase in shareholding by its controlling shareholder, Juzi Holding Co., Ltd. The plan involves Juzi Holding investing no less than HK$200 million to increase its stake in Giant Biogene within the next three to six months. Currently, Juzi Holding owns approximately 54.26% of the company's issued shares. This strategic move is based on Juzi Holding's confidence in the company's business development and growth potential. The Board of Giant Biogene views this action as a demonstration of the controlling shareholder's long-term commitment and strong confidence in the company's prospects. Shareholders and potential investors are advised to exercise caution when dealing with the company's shares.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1207","symbol_name":"个人用品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL3RrzjL:1","article_id":"2542389874","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542389874","pubTimestamp":1749443499,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Giant Biogene Holding Co., Ltd, a company incorporated in the Cayman Islands, has announced a proposed increase in shareholding by its controlling shareholder, Juzi Holding Co., Ltd. The plan involves Juzi Holding investing no less than HK$200 million to increase its stake in Giant Biogene within the next three to six months. Currently, Juzi Holding owns approximately 54.26% of the company's issued shares. This strategic move is based on Juzi Holding's confidence in the company's business development and growth potential. The Board of Giant Biogene views this action as a demonstration of the controlling shareholder's long-term commitment and strong confidence in the company's prospects. Shareholders and potential investors are advised to exercise caution when dealing with the company's shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1207":"个人用品","02367":"巨子生物","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","SG9999004311.SGD":"Nikko AM Shenton Emerging Enterprise Discovery Fund SGD"},"translate_title":"Giant Biogene Holding Co Ltd.控股股东计划2亿港元股权投资增加","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02367":0.9},"content_text":"Giant Biogene Holding Co Ltd.'s Controlling Shareholder Plans HK$200 Million Equity Investment Increase\n    \n\n        Giant Biogene Holding Co., Ltd, a company incorporated in the Cayman Islands, has announced a proposed increase in shareholding by its controlling shareholder, Juzi Holding Co., Ltd. The plan involves Juzi Holding investing no less than HK$200 million to increase its stake in Giant Biogene within the next three to six months. Currently, Juzi Holding owns approximately 54.26% of the company's issued shares. This strategic move is based on Juzi Holding's confidence in the company's business development and growth potential. The Board of Giant Biogene views this action as a demonstration of the controlling shareholder's long-term commitment and strong confidence in the company's prospects. Shareholders and potential investors are advised to exercise caution when dealing with the company's shares.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}